Aprea Therapeutics News

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.

Mar 28 18:00 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren

Mar 28 18:00 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.

Mar 14 20:55 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.

Mar 14 20:55 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III

Mar 14 20:55 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren

Mar 14 20:55 ET

Aprea Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sio Capital Management, LLC(7.49%)

Feb 14 08:04 ET

Aprea Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(9.4%),Orin H(9.4%)

Feb 7 18:57 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pamukcu Rifat

Aug 24, 2023 21:52 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Grissinger Michael

Aug 24, 2023 21:51 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III

Aug 24, 2023 21:51 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Peters Richard

Aug 24, 2023 21:50 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duey Marc

Aug 24, 2023 21:50 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.

Aug 24, 2023 21:48 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BIZZARI JEAN-PIERRE

Aug 24, 2023 21:47 ET

Aprea Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BIZZARI JEAN-PIERRE

Aug 24, 2023 21:45 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.

Jun 8, 2023 16:34 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gruia Gabriela

May 8, 2023 17:17 ET

Aprea Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Gruia Gabriela

May 8, 2023 17:16 ET

Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren

Mar 13, 2023 18:30 ET